Personal information

Activities

Collapse all

Funding (2)

Utilizing histone deacetylase inhibitors to engineer CD19-specific chimeric antigen receptor T cells

2021-01 to 2021-06 | Grant
Cardinal Bernardin Cancer Center (Maywood, US)
Source: Self-asserted source
Siao-Yi Wang

Engineering CD19-specific chimeric antigen receptor T cells without inducing cell division or differentiation

2020-07 to 2021-12 | Grant
Leukemia Research Foundation (IL, IL, US)
Source: Self-asserted source
Siao-Yi Wang
How many people are using ORCID?